A Phase III, Multi-Center, Randomized, Double-Masked, Sham Controlled Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy with Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (DERBY)
Macular Degeneration
Most Americans Unaware of One of the Leading Causes of Blindness Among Seniors
Age-Related Macular Degeneration is one of the leading causes of blindness among seniors, affecting approximately 2.1 million people nationwide[1]. By 2050, it is expected that the number will more than double to 5.4 million[2]. People …
Art, In Spite of AMD
Jefferey Lange is fascinated by the beauty and arrangement of colors and textures. As an artist diagnosed with age-related macular degeneration (AMD), Lange is acutely aware of being able to see colors and textures. Lange …
Age-Related Macular Degeneration and Stem Cells, David Gamm, MD, PhD
David Gamm, MD, PhD, discusses Age-Related Macular Degeneration and Stem Cells at the Saving Sight: Macular Degeneration Symposium in October, 2016.
Macular Degeneration and Nutrition, Julie Mares, PhD
Age-Related Macular Degeneration and Genetics, Barbara Klein, MD
The Aging Eye, Stephen Sauer, MD
Coping with Low Vision, Amy Wurf, MSEd, CLVT
Amy Wurf, MSEd, CLVT, from the Wisconsin Council of the Blind and Visually Impaired, discusses ways to cope with low vision due to age-related macular degeneration at the Saving Sight: Macular Degeneration Symposium in October, …
Research on Treatment of Age-Related Macular Degeneration, Barbara Blodi, MD
Barbara Blodi, MD, discusses current research on treatments for age-related macular degeneration at the Saving Sight: Macular Degeneration Symposium in October, 2016.